Periodic Reporting for period 2 - EPI-CART (Understanding and exploiting epigenetic regulation in CAR T cell therapy)

The dramatic efficacy of CAR T cell therapy in certain hematopoietic malignancies provides clinical validation of a groundbreaking paradigm: Human cells can be engineered into purpose-built therapeutic agents by genetically introducing artificial regulatory programs. The...